Klotho Neurosciences Inc (KLTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,150 | -708 | 1,233 | -4 | N/A |
| Depreciation Amortization | 10 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -188 | 104 | N/A | N/A | N/A |
| Other Working Capital | 151 | 261 | 486 | N/A | N/A |
| Other Operating Activity | 3,231 | -104 | -2,212 | 9 | 0 |
| Operating Cash Flow | $-2,947 | $-447 | $-493 | $5 | $N/A |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | N/A | N/A | -116,150 | N/A | N/A |
| Purchase Sale Intangibles | -124 | 24 | N/A | N/A | N/A |
| Other Investing Activity | -124 | 24 | 0 | 0 | 0 |
| Investing Cash Flow | $-124 | $24 | $-116,150 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,177 | N/A | 200 | N/A | N/A |
| Debt Repayment | N/A | N/A | -209 | N/A | N/A |
| Common Stock Issued | 175 | N/A | 120,325 | N/A | N/A |
| Common Stock Repurchased | N/A | 250 | N/A | N/A | N/A |
| Other Financing Activity | 779 | 100 | -3,338 | 0 | 0 |
| Financing Cash Flow | $3,131 | $350 | $116,979 | $N/A | $N/A |
| Beginning Cash Position | 3 | 76 | 5 | N/A | N/A |
| End Cash Position | 64 | 3 | 341 | 5 | N/A |
| Net Cash Flow | $61 | $-73 | $336 | $5 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,947 | -447 | -493 | 5 | N/A |
| Free Cash Flow | -2,947 | -447 | -493 | 5 | 0 |